<DOC>
	<DOC>NCT00208442</DOC>
	<brief_summary>The purpose of this study is to compare the performance and compare the wear characteristics of two polyethylene cup liners, Marathon™ and Enduron™, in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to one of the polyethylene cup liners, Marathon™ or Enduron™ and will be evaluated at regular intervals using clinical and x-ray assessments.</brief_summary>
	<brief_title>A Randomised Single Centre Study to Compare the Long-Term Wear Characteristics of Marathon™ and Enduron™ Polyethylene Cup Liners in Primary Total Hip Replacement</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Femoral Fractures</mesh_term>
	<mesh_term>Hip Dislocation</mesh_term>
	<mesh_term>Hip Dislocation, Congenital</mesh_term>
	<mesh_term>Slipped Capital Femoral Epiphyses</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Methyclothiazide</mesh_term>
	<criteria>i) Male or female subjects, aged between 45 and 75 years inclusive. ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained. iii) Subjects who, in the opinion of the Investigator, are able to understand this investigation, cooperate with the investigational procedures and are willing to return to the hospital for all the required postoperative followups. iv) Subjects with noninflammatory arthritis of the hip who require a primary hip arthroplasty and are considered by the Clinical Investigator to be suitable for a cemented femoral component and an uncemented acetabular component. v) Subjects who have a Charnley A classification. i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and followup in this study. ii) Women who are pregnant. iii) Subjects who are known drug or alcohol abusers or with psychological disorders that could effect followup care or treatment outcomes. iv) Subjects who have participated in a clinical study with an investigational product in the last month.</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Hip</keyword>
	<keyword>Cemented</keyword>
</DOC>